FibroBiologics is pursuing a development program for CYPS317 with the goal of advancing first-in-human clinical trials following FDA review of the IND filing. The IND submission includes comprehensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback